These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 31607567)

  • 1. Viagra Enables Efficient, Single-Day Hematopoietic Stem Cell Mobilization.
    Smith-Berdan S; Bercasio A; Rajendiran S; Forsberg EC
    Stem Cell Reports; 2019 Nov; 13(5):787-792. PubMed ID: 31607567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plerixafor: A chemokine receptor-4 antagonist for mobilization of hematopoietic stem cells for transplantation after high-dose chemotherapy for non-Hodgkin's lymphoma or multiple myeloma.
    Steinberg M; Silva M
    Clin Ther; 2010 May; 32(5):821-43. PubMed ID: 20685493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mobilization as a preparative regimen for hematopoietic stem cell transplantation.
    Chen J; Larochelle A; Fricker S; Bridger G; Dunbar CE; Abkowitz JL
    Blood; 2006 May; 107(9):3764-71. PubMed ID: 16439683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIF-1α is required for hematopoietic stem cell mobilization and 4-prolyl hydroxylase inhibitors enhance mobilization by stabilizing HIF-1α.
    Forristal CE; Nowlan B; Jacobsen RN; Barbier V; Walkinshaw G; Walkley CR; Winkler IG; Levesque JP
    Leukemia; 2015 Jun; 29(6):1366-78. PubMed ID: 25578474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes Limits Stem Cell Mobilization Following G-CSF but Not Plerixafor.
    Fadini GP; Fiala M; Cappellari R; Danna M; Park S; Poncina N; Menegazzo L; Albiero M; DiPersio J; Stockerl-Goldstein K; Avogaro A
    Diabetes; 2015 Aug; 64(8):2969-77. PubMed ID: 25804941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingosine-1-phosphate facilitates trafficking of hematopoietic stem cells and their mobilization by CXCR4 antagonists in mice.
    Juarez JG; Harun N; Thien M; Welschinger R; Baraz R; Pena AD; Pitson SM; Rettig M; DiPersio JF; Bradstock KF; Bendall LJ
    Blood; 2012 Jan; 119(3):707-16. PubMed ID: 22049516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid Mobilization Reveals a Highly Engraftable Hematopoietic Stem Cell.
    Hoggatt J; Singh P; Tate TA; Chou BK; Datari SR; Fukuda S; Liu L; Kharchenko PV; Schajnovitz A; Baryawno N; Mercier FE; Boyer J; Gardner J; Morrow DM; Scadden DT; Pelus LM
    Cell; 2018 Jan; 172(1-2):191-204.e10. PubMed ID: 29224778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational identification of a Cdc42 inhibitor presents a new regimen for long-term hematopoietic stem cell mobilization.
    Liu W; Du W; Shang X; Wang L; Evelyn C; Florian MC; A Ryan M; Rayes A; Zhao X; Setchell K; Meller J; Guo F; Nassar N; Geiger H; Pang Q; Zheng Y
    Leukemia; 2019 Mar; 33(3):749-761. PubMed ID: 30254339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plerixafor plus granulocyte colony-stimulating factor versus placebo plus granulocyte colony-stimulating factor for mobilization of CD34(+) hematopoietic stem cells in patients with multiple myeloma and low peripheral blood CD34(+) cell count: results of a subset analysis of a randomized trial.
    Nademanee AP; DiPersio JF; Maziarz RT; Stadtmauer EA; Micallef IN; Stiff PJ; Hsu FJ; Bridger G; Bolwell BJ
    Biol Blood Marrow Transplant; 2012 Oct; 18(10):1564-72. PubMed ID: 22683613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on clinical experience with AMD3100, an SDF-1/CXCL12-CXCR4 inhibitor, in mobilization of hematopoietic stem and progenitor cells.
    Pusic I; DiPersio JF
    Curr Opin Hematol; 2010 Jul; 17(4):319-26. PubMed ID: 20473162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plerixafor, a CXCR4 antagonist for the mobilization of hematopoietic stem cells.
    Uy GL; Rettig MP; Cashen AF
    Expert Opin Biol Ther; 2008 Nov; 8(11):1797-804. PubMed ID: 18847313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncostatin M regulates hematopoietic stem cell (HSC) niches in the bone marrow to restrict HSC mobilization.
    Bisht K; McGirr C; Lee SY; Tseng HW; Fleming W; Alexander KA; Matsumoto T; Barbier V; Sims NA; Müller-Newen G; Winkler IG; Bonig H; Lévesque JP
    Leukemia; 2022 Feb; 36(2):333-347. PubMed ID: 34518644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist.
    Broxmeyer HE; Orschell CM; Clapp DW; Hangoc G; Cooper S; Plett PA; Liles WC; Li X; Graham-Evans B; Campbell TB; Calandra G; Bridger G; Dale DC; Srour EF
    J Exp Med; 2005 Apr; 201(8):1307-18. PubMed ID: 15837815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plerixafor: a peripheral blood stem cell mobilizer.
    Kessans MR; Gatesman ML; Kockler DR
    Pharmacotherapy; 2010 May; 30(5):485-92. PubMed ID: 20411999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-derived circulating soluble P-selectin is sufficient to induce hematopoietic stem cell mobilization.
    Wang TF; Liou YS; Yang SH; Lin GL; Chiang YW; Lien TS; Li CC; Wang JH; Chang HH; Sun DS
    Stem Cell Res Ther; 2023 Oct; 14(1):300. PubMed ID: 37864264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New agents in HSC mobilization.
    Domingues MJ; Nilsson SK; Cao B
    Int J Hematol; 2017 Feb; 105(2):141-152. PubMed ID: 27905003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plerixafor (Mozobil) alone to mobilize hematopoietic stem cells from multiple myeloma patients for autologous transplantation.
    Flomenberg N; Comenzo RL; Badel K; Calandra G
    Biol Blood Marrow Transplant; 2010 May; 16(5):695-700. PubMed ID: 20067838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel CXCR4 antagonist for hematopoietic stem cell mobilization.
    Fricker SP
    Expert Opin Investig Drugs; 2008 Nov; 17(11):1749-60. PubMed ID: 18922110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mobilization of hematopoietic stem cells: state of the art.
    Levesque JP; Winkler IG
    Curr Opin Organ Transplant; 2008 Feb; 13(1):53-8. PubMed ID: 18660707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plerixafor and granulocyte-colony-stimulating factor (G-CSF) in patients with lymphoma and multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy for autologous hematopoietic stem cell mobilization: the Austrian experience on a named patient program.
    Worel N; Rosskopf K; Neumeister P; Kasparu H; Nachbaur D; Russ G; Namberger K; Witt V; Schloegl E; Zojer N; Linkesch W; Kalhs P; Greinix HT
    Transfusion; 2011 May; 51(5):968-75. PubMed ID: 20880037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.